Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine

ConclusionFrom our data we conclude that the combined administration of TSA and CCNU eradicates GBM cells with a higher efficacy than either drug alone, thereby opening a novel avenue for the treatment of GBM.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research